Abstract:Objective To observe the effects of initial doses and treatment timing of levothyroxine (L-T4) on the clinical effcacy in children with congenital hypothyroidism (CH). Methods This study included 98 children who had an abnormal level of thyroid stimulating hormone (TSH) in neonatal screening in four regions of Yunnan Province and who fnally had a confrmed diagnosis of CH. They received treatment with L-T4 and were divided into standard dose group (10-15 μg/kg per day) and low dose group ( Results Compared with the low dose group, the standard dose group had a signifcantly lower TSH level and a signifcantly higher free thyroxine (FT4) level at 2 weeks after treatment (P P > 0.05). The physical and neural development were not signifcantly different between the two dose groups before and at all time points after treatment (P > 0.05). At all time points after treatment, the levels of TSH and FT4 and physical development were not signifcantly different between the different starting time groups (P > 0.05). However, the Gesell score was signifcantly higher in the under 2 months old group than in the more than 2 months old group at all time points after treatment (P Conclusions The standard dose group has a better treatment outcome than the low dose group, whereas the symptoms of hyperthyroidism deserve close attention. The treatment timing is vital to the neurodevelopment of children with CH. Once diagnosed, the patients should receive treatments immediately.
YANG Jing-Hui,ZHANG Jing-Hui,ZHANG Yin-Hong et al. Analysis of treatment efficacy for congenital hypothyroidism in some regions of Yunnan Province, China[J]. CJCP, 2017, 19(7): 741-747.
Rahmani K, Yarahmadi S, Etemad K, et al. Congenital hypothyroidism:Optimal initial dosage and time of initiation of treatment:A systematic review[J]. Int J Endocrinol Metab, 2016, 14(3):e36080.
[3]
Yang RL, Zhu ZW, Zhou XL, et al. Treatment and follow-up of children with transient congenital hypothyroidism[J]. J Zhejiang Univ Sci B, 2005, 6(12):1206-1209.
[4]
Rose SR, Brown RS, Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism[J]. Pediatrics, 2006, 117(6):2290-2303.
Tuhan H, Abaci A, Cicek G, et al. Levothyroxine replacement in primary congenital hypothyroidism:the higher the initial dose the higher the rate of overtreatment[J]. J Pediatr Endocrinol Metab, 2016, 29(2):133-138.
Vaidyanathan P, Pathak M, Kaplowitz PB. In congenital hypothyroidism, an initial levothyroxine dose of 10-12μg/kg/day is suffcient and sometimes excessive based on thyroid tests 1 month later[J]. J Pediatr Endocrinol Metab, 2012, 25(9-10):849-852.
[11]
Al-Jurayyan NAM, Al-Jurayyan RNA, Al Senani AMS. Effcacy of a high initial dose of L-thyroxine in the treatment of congenital hypothyroidism[J]. Curr Pediatr Res, 2010, 14(2):125-130.
[12]
Salerno M, Militerni R, Bravaccio C, et al. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism[J]. Thyroid, 2002, 12(1):45-52.
Nili S, Ghaderi E, Ghotbi N, et al. Comparison of IQ between patients with treated congenital hypothyroidism and healthy children in the Kurdish population-A historical cohort[J]. Acta Endocrinologica, 2015, 11(3):299.
[16]
Gilbert ME, Rovet J, Chen Z, et al. Developmental thyroid hormone disruption:prevalence, environmental contaminants and neurodevelopmental consequences[J]. Neurotoxicology, 2011, 33(4):842-852.